Gevorg Tamamyan: Happy Birthday OncoDaily

FDA Grants Approval for Oral Decitabine/Cedazuridine with Venetoclax in Newly Diagnosed AML

How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Herbert Loong Invites to Attend the Sarcoma Grand Rounds at ASCO 2026

Grand Rounds by OncoDaily: AI in Oncology Edition

Calculators

Bone Scan Index (BSI) Tracker

Tracks percentage of skeletal tumor burden and change from baseline in metastatic bone disease. Designed for longitudinal monitoring and documentation of disease trend.

Baseline (Optional)

Trend thresholds: Stable within ±10% of baseline | Increase >10% | Decrease >10%